AP3B2
Basic information
Region (hg38): 15:82659281-82710112
Links
Phenotypes
GenCC
Source:
- undetermined early-onset epileptic encephalopathy (Supportive), mode of inheritance: AD
- developmental and epileptic encephalopathy, 48 (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 48 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 27431290; 27431290 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (19 variants)
- Developmental and epileptic encephalopathy, 48 (5 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AP3B2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 207 | 213 | ||||
missense | 278 | 284 | ||||
nonsense | 14 | |||||
start loss | 1 | |||||
frameshift | 14 | 20 | ||||
inframe indel | 9 | |||||
splice donor/acceptor (+/-2bp) | 10 | |||||
splice region | 24 | 41 | 3 | 68 | ||
non coding | 118 | 10 | 132 | |||
Total | 23 | 16 | 297 | 331 | 16 |
Highest pathogenic variant AF is 0.0000131
Variants in AP3B2
This is a list of pathogenic ClinVar variants found in the AP3B2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-82659466-T-G | Uncertain significance (Dec 01, 2022) | |||
15-82659567-G-A | Inborn genetic diseases | Uncertain significance (Jul 06, 2023) | ||
15-82659567-G-C | Uncertain significance (Jul 21, 2022) | |||
15-82659573-G-T | Developmental and epileptic encephalopathy, 48 | Uncertain significance (Sep 27, 2022) | ||
15-82659579-A-G | Uncertain significance (Jun 03, 2022) | |||
15-82659583-C-G | Uncertain significance (Jan 02, 2022) | |||
15-82659585-TC-T | Uncertain significance (Mar 26, 2021) | |||
15-82659593-C-A | Likely benign (Dec 22, 2021) | |||
15-82659593-C-T | Likely benign (May 30, 2023) | |||
15-82659599-G-A | Likely benign (Nov 27, 2023) | |||
15-82659599-G-C | Likely benign (Jan 18, 2024) | |||
15-82659602-G-A | Likely benign (Nov 27, 2023) | |||
15-82659612-A-G | Uncertain significance (Apr 15, 2022) | |||
15-82659619-C-T | Uncertain significance (Jun 30, 2022) | |||
15-82659620-G-A | Likely benign (Dec 06, 2023) | |||
15-82659624-T-C | Uncertain significance (May 03, 2021) | |||
15-82659626-G-T | Likely benign (Jan 03, 2022) | |||
15-82659627-ACAGT-A | not specified | Conflicting classifications of pathogenicity (Dec 21, 2023) | ||
15-82659635-C-T | Likely benign (Apr 05, 2022) | |||
15-82659636-T-C | Uncertain significance (Oct 13, 2023) | |||
15-82659636-TGGGC-CGGGG | Uncertain significance (Oct 07, 2019) | |||
15-82659640-C-G | Uncertain significance (Oct 13, 2023) | |||
15-82659647-A-G | Likely benign (Oct 30, 2022) | |||
15-82659654-C-T | Inborn genetic diseases | Uncertain significance (Oct 26, 2022) | ||
15-82659655-G-A | Inborn genetic diseases | Likely benign (Apr 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AP3B2 | protein_coding | protein_coding | ENST00000261722 | 26 | 50634 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.772 | 0.228 | 124621 | 0 | 29 | 124650 | 0.000116 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.92 | 413 | 617 | 0.669 | 0.0000342 | 6997 |
Missense in Polyphen | 57 | 143.83 | 0.3963 | 1533 | ||
Synonymous | -0.146 | 253 | 250 | 1.01 | 0.0000142 | 2174 |
Loss of Function | 5.37 | 11 | 53.3 | 0.206 | 0.00000262 | 631 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000465 | 0.000465 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000928 | 0.0000928 |
European (Non-Finnish) | 0.000116 | 0.000115 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000655 | 0.0000654 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Subunit of non-clathrin- and clathrin-associated adaptor protein complex 3 (AP-3) that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules. AP-3 appears to be involved in the sorting of a subset of transmembrane proteins targeted to lysosomes and lysosome-related organelles. In concert with the BLOC-1 complex, AP-3 is required to target cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals.;
- Disease
- DISEASE: Epileptic encephalopathy, early infantile, 48 (EIEE48) [MIM:617276]: A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE48 is an autosomal recessive form characterized by onset of seizures in the first year of life. Affected individuals manifest global developmental delay, intellectual disability, absent speech, and poor, if any, motor development. {ECO:0000269|PubMed:27431290, ECO:0000269|PubMed:27889060}. Note=The disease may be caused by mutations affecting the gene represented in this entry.;
- Pathway
- Lysosome - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- rvis_EVS
- -1.62
- rvis_percentile_EVS
- 2.93
Haploinsufficiency Scores
- pHI
- 0.283
- hipred
- Y
- hipred_score
- 0.671
- ghis
- 0.637
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.929
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ap3b2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hearing/vestibular/ear phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- intracellular protein transport;post-Golgi vesicle-mediated transport;anterograde axonal transport;anterograde synaptic vesicle transport
- Cellular component
- Golgi apparatus;AP-3 adaptor complex;COPI-coated vesicle;clathrin-coated vesicle membrane;axon cytoplasm
- Molecular function
- transporter activity